Invitation for Expression of Interest (EoI) for Transfer of Technology SHetA2 Cervical Cancer Drug useful in treatment of HPV induced Cervical Dysplasia and/or Cervical Cancer (Drug Candidate) ICMR/EoI/PM/38/Cervical Cancer Drug/20 Last Date: May 20, 2026



